Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cesarman, E
Right arrow Articles by Chang, Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cesarman, E
Right arrow Articles by Chang, Y
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences

E Cesarman, PS Moore, PH Rao, G Inghirami, DM Knowles and Y Chang

Department of Pathology, New York Hospital-Cornell Medical Center, New York 10021, USA.

Two unique DNA fragments were recently identified in over 90% of acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma tissues. Sequence analysis suggests that these fragments belong to a previously unidentified human herpesvirus, Kaposi's sarcoma-associated herpesvirus (KSHV). These fragments have also been identified in a subset of non-Hodgkin's lymphomas in human immunodeficiency virus- positive patients; specifically, in body cavity-based lymphomas (AIDS- BCBLs). We have established two cell lines derived from AIDS-BCBLs, BC- 1 and BC-2, which retain the KSHV sequences, and have used them to further characterize this putative viral genome. In this report, we demonstrate that the KSHV sequences represent a portion of a much larger DNA molecule that is located predominantly in the nucleus of the infected cells. In situ hybridization of metaphase spreads made from both of these cell lines show these sequences in episomal structures. Their presence in the cells as large nuclear episomes supports previous sequence homology data suggesting that KSHV belongs to the herpesvirus family. These cell lines provide a continuous source of KSHV sequences. Thus, they represent an important tool for future studies of this recently described human herpesvirus that may be involved in the pathogenesis of Kaposi's sarcoma and some AIDS-related non-Hodgkin's lymphomas.

Volume 86, Issue 7, pp. 2708-2714, 10/01/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
T. Xia, A. O'Hara, I. Araujo, J. Barreto, E. Carvalho, J. B. Sapucaia, J. C. Ramos, E. Luz, C. Pedroso, M. Manrique, et al.
EBV MicroRNAs in Primary Lymphomas and Targeting of CXCL-11 by ebv-mir-BHRF1-3
Cancer Res., March 1, 2008; 68(5): 1436 - 1442.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y.-J. Zhang, R. S. Bonaparte, D. Patel, D. A. Stein, and P. L. Iversen
Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus
Mol. Cancer Ther., March 1, 2008; 7(3): 712 - 720.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Wies, Y. Mori, A. Hahn, E. Kremmer, M. Sturzl, B. Fleckenstein, and F. Neipel
The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells
Blood, January 1, 2008; 111(1): 320 - 327.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Z. Gandy, S. D. Linnstaedt, S. Muralidhar, K. A. Cashman, L. J. Rosenthal, and J. L. Casey
RNA Editing of the Human Herpesvirus 8 Kaposin Transcript Eliminates Its Transforming Activity and Is Induced during Lytic Replication
J. Virol., December 15, 2007; 81(24): 13544 - 13551.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. L. Skalsky, J. Hu, and R. Renne
Analysis of Viral cis Elements Conferring Kaposi's Sarcoma-Associated Herpesvirus Episome Partitioning and Maintenance
J. Virol., September 15, 2007; 81(18): 9825 - 9837.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Ye, L. Gradoville, D. Daigle, and G. Miller
De Novo Protein Synthesis Is Required for Lytic Cycle Reactivation of Epstein-Barr Virus, but Not Kaposi's Sarcoma-Associated Herpesvirus, in Response to Histone Deacetylase Inhibitors and Protein Kinase C Agonists
J. Virol., September 1, 2007; 81(17): 9279 - 9291.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
G. Donofrio, S. Herath, C. Sartori, S. Cavirani, C. F. Flammini, and I. M. Sheldon
Bovine herpesvirus 4 is tropic for bovine endometrial cells and modulates endocrine function
Reproduction, July 1, 2007; 134(1): 183 - 197.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Xu, T. Coleman, J. Zhang, A. Fagot, C. Kotalik, L. Zhao, P. Trivedi, C. Jones, and L. Zhang
Epstein-Barr Virus Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication in Primary Effusion Lymphomas
J. Virol., June 1, 2007; 81(11): 6068 - 6078.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Zeng, X. Zhang, Z. Huang, L. Cheng, S. Yao, D. Qin, X. Chen, Q. Tang, Z. Lv, L. Zhang, et al.
Intracellular Tat of Human Immunodeficiency Virus Type 1 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus: Role of JAK/STAT Signaling
J. Virol., March 1, 2007; 81(5): 2401 - 2417.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. E. Petre, S.-H. Sin, and D. P. Dittmer
Functional p53 Signaling in Kaposi's Sarcoma-Associated Herpesvirus Lymphomas: Implications for Therapy
J. Virol., February 15, 2007; 81(4): 1912 - 1922.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Wang, Q. Tang, G. G. Maul, and Y. Yuan
Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: Dual Role of Replication and Transcription Activator
J. Virol., December 15, 2006; 80(24): 12171 - 12186.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
G. Donofrio, S. Cavirani, A. Vanderplasschen, L. Gillet, and C. F. Flammini
Recombinant Bovine Herpesvirus 4 (BoHV-4) Expressing Glycoprotein D of BoHV-1 Is Immunogenic and Elicits Serum-Neutralizing Antibodies against BoHV-1 in a Rabbit Model
Clin. Vaccine Immunol., November 1, 2006; 13(11): 1246 - 1254.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. You, V. Srinivasan, G. V. Denis, W. J. Harrington Jr., M. E. Ballestas, K. M. Kaye, and P. M. Howley
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Bromodomain Protein Brd4 on Host Mitotic Chromosomes.
J. Virol., September 1, 2006; 80(18): 8909 - 8919.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Lan, T. Choudhuri, M. Murakami, D. A. Kuppers, and E. S. Robertson
Intracellular Activated Notch1 Is Critical for Proliferation of Kaposi's Sarcoma-Associated Herpesvirus-Associated B-Lymphoma Cell Lines In Vitro.
J. Virol., July 1, 2006; 80(13): 6411 - 6419.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Lu, L. Day, S.-J. Gao, and P. M. Lieberman
Acetylation of the Latency-Associated Nuclear Antigen Regulates Repression of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
J. Virol., June 1, 2006; 80(11): 5273 - 5282.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. A. Keller, D. Hernandez-Hopkins, J. Vider, V. Ponomarev, E. Hyjek, E. J. Schattner, and E. Cesarman
NF-{kappa}B is essential for the progression of KSHV- and EBV-infected lymphomas in vivo
Blood, April 15, 2006; 107(8): 3295 - 3302.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. Cohen, C. Brodie, and R. Sarid
An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus.
J. Gen. Virol., April 1, 2006; 87(Pt 4): 795 - 802.
[Abstract] [Full Text] [PDF]


Home page
Adv. Dent. Res.Home page
C.G. Teo
Conceptual Emergence of Human Herpesvirus 8 (Kaposi's Sarcoma-associated Herpesvirus) as an Oral Herpesvirus
Adv. Dent. Res., April 1, 2006; 19(1): 85 - 90.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Sarek, A. Jarviluoma, and P. M. Ojala
KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas
Blood, January 15, 2006; 107(2): 725 - 732.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. L. Taylor, H. N. Bennett, B. A. Snyder, P. S. Moore, and Y. Chang
Transcriptional Analysis of Latent and Inducible Kaposi's Sarcoma-Associated Herpesvirus Transcripts in the K4 to K7 Region
J. Virol., December 15, 2005; 79(24): 15099 - 15106.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Chang, D. P. Dittmer, S.-Y. Chul, Y. Hong, and J. U. Jung
Role of Notch Signal Transduction in Kaposi's Sarcoma-Associated Herpesvirus Gene Expression
J. Virol., November 15, 2005; 79(22): 14371 - 14382.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Chen and M. Lagunoff
Establishment and Maintenance of Kaposi's Sarcoma-Associated Herpesvirus Latency in B Cells
J. Virol., November 15, 2005; 79(22): 14383 - 14391.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Pearce, S. Matsumura, and A. C. Wilson
Transcripts Encoding K12, v-FLIP, v-Cyclin, and the MicroRNA Cluster of Kaposi's Sarcoma-Associated Herpesvirus Originate from a Common Promoter
J. Virol., November 15, 2005; 79(22): 14457 - 14464.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. S. Johnson, N. Maronian, and J. Vieira
Activation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Gene Expression during Epithelial Differentiation
J. Virol., November 1, 2005; 79(21): 13769 - 13777.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Lu, L. Day, and P. M. Lieberman
Kaposi's Sarcoma-Associated Herpesvirus Virion-Induced Transcription Activation of the ORF50 Immediate-Early Promoter
J. Virol., October 15, 2005; 79(20): 13180 - 13185.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
E. Trento, C. Castilletti, C. Ferraro, I. Lesnoni La Parola, A. Mussi, L. Muscardin, V. Bordignon, G. D'Agosto, A. Amantea, A. Mastroianni, et al.
Human Herpesvirus 8 Infection in Patients With Cutaneous Lymphoproliferative Diseases
Arch Dermatol, October 1, 2005; 141(10): 1235 - 1242.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Bechtel, A. Grundhoff, and D. Ganem
RNAs in the Virion of Kaposi's Sarcoma-Associated Herpesvirus
J. Virol., August 15, 2005; 79(16): 10138 - 10146.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
P. Gasperini, M. Barbierato, C. Martinelli, P. Rigotti, F. Marchini, G. Masserizzi, F. Leoncini, L. Chieco-Bianchi, T. F. Schulz, and M. L. Calabro
Use of a BJAB-Derived Cell Line for Isolation of Human Herpesvirus 8
J. Clin. Microbiol., June 1, 2005; 43(6): 2866 - 2875.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. Van Dross, S. Yao, S. Asad, G. Westlake, D. J. Mays, L. Barquero, S. Duell, J. A. Pietenpol, and P. J. Browning
Constitutively Active K-cyclin/cdk6 Kinase in Kaposi Sarcoma-Associated Herpesvirus-Infected Cells
J Natl Cancer Inst, May 4, 2005; 97(9): 656 - 666.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. T. Bechtel, R. C. Winant, and D. Ganem
Host and Viral Proteins in the Virion of Kaposi's Sarcoma-Associated Herpesvirus
J. Virol., April 15, 2005; 79(8): 4952 - 4964.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. M. Moser, J. W. Upton, K. S. Gray, and S. H. Speck
Ex Vivo Stimulation of B Cells Latently Infected with Gammaherpesvirus 68 Triggers Reactivation from Latency
J. Virol., April 15, 2005; 79(8): 5227 - 5231.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Grimm, S. Schneider, E. Naschberger, J. Huber, E. Guenzi, A. Kieser, P. Reitmeir, T. F. Schulz, C. A. Morris, and M. Sturzl
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX
Blood, April 15, 2005; 105(8): 3263 - 3269.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Cai, S. Lu, Z. Zhang, C. M. Gonzalez, B. Damania, and B. R. Cullen
Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells
PNAS, April 12, 2005; 102(15): 5570 - 5575.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Lu, Y. Zeng, Z. Huang, L. Huang, C. Qian, G. Tang, and D. Qin
Human Herpesvirus 6 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus
Am. J. Pathol., January 1, 2005; 166(1): 173 - 183.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Lu, J. Suen, C. Frias, R. Pfeiffer, M.-H. Tsai, E. Chuang, and S. L. Zeichner
Dissection of the Kaposi's Sarcoma-Associated Herpesvirus Gene Expression Program by Using the Viral DNA Replication Inhibitor Cidofovir
J. Virol., December 15, 2004; 78(24): 13637 - 13652.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Srinivasan, T. Komatsu, M. E. Ballestas, and K. M. Kaye
Definition of Sequence Requirements for Latency-Associated Nuclear Antigen 1 Binding to Kaposi's Sarcoma-Associated Herpesvirus DNA
J. Virol., December 15, 2004; 78(24): 14033 - 14038.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Jarviluoma, S. Koopal, S. Rasanen, T. P. Makela, and P. M. Ojala
KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas
Blood, November 15, 2004; 104(10): 3349 - 3354.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J.-H. Deng, Y.-J. Zhang, X.-P. Wang, and S.-J. Gao
Lytic Replication-Defective Kaposi's Sarcoma-Associated Herpesvirus: Potential Role in Infection and Malignant Transformation
J. Virol., October 15, 2004; 78(20): 11108 - 11120.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. C. Verma, S. Borah, and E. S. Robertson
Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Up-Regulates Transcription of Human Telomerase Reverse Transcriptase Promoter through Interaction with Transcription Factor Sp1
J. Virol., October 1, 2004; 78(19): 10348 - 10359.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Ohsaki, K. Ueda, S. Sakakibara, E. Do, K. Yada, and K. Yamanishi
Poly(ADP-Ribose) Polymerase 1 Binds to Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Terminal Repeat Sequence and Modulates KSHV Replication in Latency
J. Virol., September 15, 2004; 78(18): 9936 - 9946.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Wang, H. Li, M. Y. Chan, F. X. Zhu, D. M. Lukac, and Y. Yuan
Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: cis-Acting Requirements for Replication and ori-Lyt-Associated RNA Transcription
J. Virol., August 15, 2004; 78(16): 8615 - 8629.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. R. Staudt, Y. Kanan, J. H. Jeong, J. F. Papin, R. Hines-Boykin, and D. P. Dittmer
The Tumor Microenvironment Controls Primary Effusion Lymphoma Growth in Vivo
Cancer Res., July 15, 2004; 64(14): 4790 - 4799.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Lim, C. Choi, and J. Choe
Mitotic Chromosome-Binding Activity of Latency-Associated Nuclear Antigen 1 Is Required for DNA Replication from Terminal Repeat Sequence of Kaposi's Sarcoma-Associated Herpesvirus
J. Virol., July 1, 2004; 78(13): 7248 - 7256.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Lan, D. A. Kuppers, S. C. Verma, and E. S. Robertson
Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Inhibits Lytic Replication by Targeting Rta: a Potential Mechanism for Virus-Mediated Control of Latency
J. Virol., June 15, 2004;